β,
RESULTS
NFs containing extensively phosphorylated NF-H are expressed by and incorporated into the cytoskeleton of differentiated NB2a/d1 cells (Fig. 1A,B) . In efforts to identify which kinase(s) were predominantly responsible for generation of commonly-studied NF phospho-epitopes, we overexpressed the known NF kinases cdk5, MAPk, GSK and CK1. Increased activity of cdk5 and MAPk have previously been demonstrated within these cells following transfection with p25 and constitutivelyactive MKK1 (Chan et al., 2004; Shea et al., 2004) . We confirmed increased activity of GSK and CK1
following transfection and inhibition following lithium and D4476 treatment (Fig. 1C,D) . Homogenates of cells overexpressing these kinases were subjected to immunoblot analyses. Since NB2a/d1 cells contain robust levels of phospho-and nonphospho-NFs (Fig. 1B) , in order to facilitate detection of any changes in epitopes following selective kinase activation, total aliquots loaded onto gels were restricted such that the levels in non-transfected cells were barely detectable (Fig. 1E ). These analyses indicated that the SMI-31, SMI-34 and RT97 epitopes were predominantly generated by MAPk. By contrast, the RMO-24 epitope was predominantly generated by GSK (Fig. 1E ).
To investigate further the potential roles of phosphorylation of NFs by these kinases on NF phosphorylation, we transfected cells with GFP-tagged NF constructs, which facilitated monitoring levels and distribution of newly-expressed NFs independently of differentially-phosphorylated endogenous NFs. In addition, expression of GFP-tagged constructs allowed us to more closely monitor the influence of kinase manipulation on NF dynamics without interference of endogenous NFs.
CK1 mediates the major retardation of NF-H migration on SDS-gels
Phosphorylation alters NF-H migration on SDS gels from 160kDa to 200kDa (Nixon and Shea, 1992) . To determine the responsible kinase(s), we treated cells expressing GFP-H with the above kinase inhibitors plus the casein kinase 2 (CK2) inhibitor tBBT. The bulk of GFP-H migrated at 195kDa (Fig. 2), corresponding to hypophosphorylated (160kDa) NF-H fused to 35kDa GFP; GFP-H was also detected at 260kDa (extensively phosphorylated NF-H fused to GFP . Phospho-H immunoreactivity was concentrated at the 260kDa isoform for untreated and lithium, PD98059 and roscovitine-treated homogenates. D4476 increased 195kDa phospho-dependent reactivity and reduced 260kDa phospho-dependent reactivity (Fig. 2) . D4476 did not alter GFP-H distribution, indicating that this shift in phospho-reactivity was not due to altered migration of total NF-H.
This finding suggests that (1) phosphorylation events mediated by CK1 are critical for inducing the migratory shift of NF-H to 200kDa, (2) phosphorylation events mediated by MAPk, cdk5 and GSK are not sufficient to induce this migratory shift, and (3) SMI-31, SMI-34 and RT97 phospho-epitopes can be generated in the absence of the migratory shift.
Cdk5 and GSK mediate relatively minor changes in NF migration on SDS-gels
The broad band observed for extensively-phosphorylated NF-H on SDS gels can be resolved into multiple phospho-dependent isoforms on low acrylamide gels (Lewis and Nixon, 1988) . GFP-H, and its resultant phospho-isoforms, also appear as a relatively broad band; e.g., the phospho-isoform migrating at 260kDa spans approx. 10kDa (e.g., Fig. 3A ). To examine further the impact of the above kinases on NF-H migration, we transfected cells with constructs expressing GFP-tagged C-terminal sidearms, including site-directed mutants in which the serine residues of cdk5 consensus sequences had been replaced by aspartates (asp) or alanines (ala), termed GFP-Hasp and GFP-Hala, along with GFP-H wt (i.e., the normal NF-H sidearm) to mimic permanently phosphorylated or nonphosphorylated states . These site-specific mutations allowed monitoring of potential impact of cdk5 on isoform migration. In addition, these "tail only" constructs were more sensitive to subtle migratory shifts than were full-length constructs (e.g., Fig. 3B ).
SMI-31 and RT97 in wt sidearms resolved on low acrylamide SDS-gels into two distinct isoforms migrating at approximately 200 and 205kDa. RMO-24 immunoreactivity was exclusively associated with the 205kDa isoform and a 210kDa isoform; Fig. 3C ). The sidearm construct with ala substitutions revealed a unique isoform migrating at approx. 190kDa, coupled with the loss of the SMI-31/RT97-reactive 200kDa isoform (Fig. 3D ). RMO-24 immunoreactive isoforms were not affected. This suggests that the migratory shift of this isoform from 190 to 200kDa is mediated by cdk5, since the ala substitution specifically blocked cdk5-mediated phosphorylation. Migration of the 205kDa isoform was not affected, suggesting that its migration was not dependent upon cdk5 activity (Fig. 3D) . No difference was detected between migration of GFP-Hasp and GFP-Hwt sidearms, consistent with the presence of endogenous cdk5 activity in NB2a/d1 cells Shea et al., 2004) .
The majority of RMO-24 immunoreactivity was derived from GSK, since RMO-24 immunoreactivity was reduced by 61 ± 6% following lithium treatment; the 210kDa RMO-24-reactive isoform was more severely depleted, and the 205kDa isoform was relatively increased (Fig. 3E ). This pattern of reduction in isoform reactivity was also observed following probing of additional replicas with a polyclonal antibody (R39) directed against all NFs regardless of phosphorylation state. These findings indicated that GSK played a role in shifting the migration of the 205kDa isoform to 210kDa.
By contrast, the 210kDa isoform was not depleted in asp sidearms (Fig. 3E ). Since asp sidearms were mutated exclusively at cdk5 consensus sites, this finding indicated that cdk5-mediated phosphorylation played a role in generation of the 210kDa isoform in addition to that of GSK. PD98059 treatment also depleted the RMO-24-reactive 210kDa isoform, coupled with an increase in the 205kDa isoform, suggesting that MAPk-mediated phosphorylation also contributes to generation of the 210kDa form.
While the major shift in migration of NF-H on SDS-gels apparently mediated by CK1 ( Fig. 2 ), these findings demonstrate that generation of the full range of NF-H isoforms involves MAPk, cdk5 and GSK. In contrast to other phospho-dependent NF antibodies, immunoreactivity of NF-H with in non-transfected cells is difficult to detect by immunoblot analyses. However, when the stacking gel was retained for transfer to nitrocellulose, RMO-24 immunoreactivity was observed within the stack, suggesting that the majority of endogenous RMO-24-reactive NF-H isoforms are associated with SDSresistant complexes (Fig. 3F ). This possibility was confirmed by treatment of cytoskeletal preparations with 8M urea to dissociate NF complexes (Marston and Hartley, 1990) , which eliminated RMO-24 immunoreactivity within the stack, increased immunoreactivity associated with the anticipated migratory position for extensively phosphorylated NF-H. Notably, some SMI-31 and SMI-34 reactivity was observed within this aggregate (Fig. 3F ). This is also consistent with detection of the nearly all RMO-24 immunoreactivity within in the axonal NF bundle in immunofluorescent analyses ( Fig. 1 ).
Multiple kinases contribute to NF bundling
Axonal neurites contain a centrally-situated bundle of closely-opposed NFs that undergo transport and turnover more slowly than the surrounding individual NFs (Fig. 1A) . Bundled NFs can be separated from surrounding individual NFs by sedimentation over sucrose, indicating that they are physically associated (Kushkuley et al., 2009 ). NF-NF associations leading to bundling are mediated by cationdependent cross-bridging of phospho-NFs (Kushkuley et al., 2009; Yabe et al., 2001a) . To investigate which kinase(s) mediate critical events that promote NF-NF associations, we compared the impact of kinase overexpression or inhibition on intracellular GFP-H distribution, GSK activity and, to a lesser extent, cdk5 and MAPk activity increased NF-NF associations, while, by contrast, CK1 activity decreased NF-NF associations (Fig. 4C, D) .
We also examined the impact of kinase activity in cell-free analyses (Fig. 4E ). Individual NFs recovered from spinal cord were conjugated with rhodamine and incubated with and without purified kinases, after which we quantified the percentage of NFs that were associated with ≥ 3 other NFs (Kushkuley et al., 2009 ). In these cell-free analyses, we were also able to treat isolated NFs with multiple kinases; this was not practical to attempt within intact cells, since such would require transfection with multiple kinase constructs. In cell-free analyses, neither MAPk nor GSK promoted NF-NF associations individually or in combination. Consistent with prior studies (Kushkuley et al., 2009 ), cdk5 induced an approximate 40% increase in NF-NF associations. By contrast, cdk5 and GSK induced NF-NF associations for approximately 90% of NFs, indicating a synergistic impact of these kinases on NF bundling. Notably, incubation with cdk5, GSK and MAPk attenuated the extent of NF-NF associations observed following incubation with cdk5 and GSK to the level observed following incubation with cdk5 alone. This was consistent with the possibility that MAPk interfered specifically with the impact of GSK, and not that of cdk5, on NF-NF associations.
Phosphorylation by cdk5 and MAPk prevent NF Proteolysis
C-terminal phosphorylation inhibits NF proteolysis (Grant et al., 2001; Pant and Veeranna, 1995) .
We therefore compared the relative contribution of these NF kinases to protection against proteolysis.
To accomplish this, we treated cells with the pharmacological inhibitors roscovitine, PD98059, lithium and D4476, none of which altered GFP-H levels in isolation (Fig. 5A) . However, combined treatment with roscovitine and PD98059 significantly reduced total GFP-H and RT97-reactive NF-H (Fig. 5A ).
By contrast, reduction was not observed following treatment with individually or in combination.
Moreover, overexpression of GSK or CK1 could not prevent GFP-H depletion following combined treatment with roscovitine and PD98059 (Fig. 5B ). These findings indicate that phosphorylation events mediated by cdk5 and MAPk, but not by GSK or CK1, protect NFs from proteolysis. Consistent with recent studies , phospho-NFs within bundles were more resistant to proteolysis than were NFs in homogenates (Fig. 5C ). Cdk5 and MAPk may therefore maintain a critical level of NFs, which would indirectly promote NF bundling.
MAPk mediates anterograde NF transport by inhibiting GSK-mediated NF bundling
MAPk activity is required for transport of NFs into and along axons (Chan et al., 2004) but the responsible mechanism remains unclear. Notably, MAPk inactivates GSK (Ding et al., 2005) . Herein, we demonstrate that GSK participates in NF bundling, while MAPk attenuated GSK-mediated bundling (Fig. 4) . Since NFs that undergo bundling are withdrawn from the transporting pool , we considered that the mechanism by which MAPk mediates NF transport may be by inhibiting GSK-mediated NF-NF interactions.
If this were indeed the case, we considered that inhibition of NF transport by treatment with PD98059 coupled with overexpression of GSK may have an additive effect. To test this possibility, we first confirmed that MAPk phosphorylated GSK at ser 9 (Fig. 6A ). Overexpression of GSK in which ser9 was mutated to ala ("GSKala," which cannot be inactivated by phosphorylation and is therefore constitutively active) inhibited NF transport into and along axonal neurites (Fig. 6B ). Treatment with PD98059 (which inhibits MAPk activity) inhibits NF transport and fosters perikaryal NF accumulation (Chan et al., 2004 ) (see also Fig. 6C for representative image). However, when cells overexpressing GSKala were treated with PD98059, we observed an increase in perikaryal NF bundles (Fig. 6C ).
These findings indicate that MAPk promotes NF axonal transport by inhibiting GSK activity, and in doing so, may preclude inappropriate perkaryal NF bundling.
GSK potentiates cdk5-induced NF bundling
Overexpression of cdk5 induces the accumulation of phospho-NF bundles within perikarya . Given the above demonstration of a critical role for GSK in perikaryal NF accumulation, we questioned whether or not GSK participated in cdk5-induced perikaryal NF accumulation. To investigate this possibility, we overexpressed GFP-H along with p25 or GSK, and treated cells with lithium or roscovitine (active against GSK and cdk5, respectively) prior to harvest. Both p25 and GSK overexpression increased the percentage of cells with perikaryal NF bundles. However, treatment with lithium inhibited p25-induced perikaryal NF accumulation, and treatment with roscovitine inhibited perikaryal NF accumulation induced by GSK (Fig. 6D ). These findings indicate that a combination of 1 0 cdk5 and GSK activity is required to induce perikaryal NF accumulations, and are consistent with our demonstration that GSK potentiated cdk5-induced NF-NF associations in cell-free analyses (Fig. 4) .
CK1 inhibits NF phosphorylation within perikarya by maintaining phosphatase activity
The above results (Fig. 4) indicated that CK1 apparently inhibited NF bundling. This finding seemed counterintuitive, since CK1 activity was responsible for the shift in NF-H migration on SDS gels attributed to extensive phosphorylation (Fig. 2) , and bundles contain the bulk of extensively phosphorylated NFs (Kushkuley et al., 2009; Yabe et al., 2001a) . We therefore examined the levels and distribution of total (GFP-H) and RT97-reactive NF-H within total homogenates and bundle fractions derived from cells following overexpression of CK1 and treatment with D4476 (a pharmacological inhibitor active against CK1) (Fig. 7A ). Visual inspection, confirmed by densitometric analyses, revealed that overexpression of CK1 statistically reduced total RT97 immunoreactivity (p<0.01, ANOVA), while treatment with D4476 statistically increased total RT97 immunoreactivity (p<0.01, ANOVA). Overexpression of CK1 decreased the amount of total and RT97-reactive NF-H within bundles (trend towards significance, p<0.06, ANOVA) while treatment with D4476 increased the amount of total and RT97-reactive NF-H within bundles (trend towards significance, p<0.08, ANOVA).
Immunofluorescent analyses demonstrated an increase in axonal and perikaryal RT97 reactivity following D4476 treatment (Fig. 7B ).
Since CK1 activates protein phosphatase 1 (PP1) (Henry and Killilea, 1993) , we probed whether or not CK1 regulated NF dynamics via modulation of PP1 activity. D4476 treatment significantly (p<0.05) reduced PP1 but not PP2a activity in perikarya and axonal neurites (Fig. 7C ). Calyculin, a pharmacological agent active against PP1, fostered the formation of SDS-resistant high-molecular weight material that was reactive with RT97 but not the nonphospho-NF antibody SMI-32 (Fig. 7D ) and increased RT97 immunoreactivity within perikarya and axonal neurites (Fig. 7E ). These findings indicate that PP1 activity regulates NF-H C-terminal phosphorylation, including restricting phospho-NF accumulation within perikarya, and that CK1 may restrict NF phosphorylation by activation of PP1.
MAPk, cdk5, CK1 and GSK each contribute to axonal NF bunding
The above findings highlight that the activity of MAPk, cdk5, CK1 and GSK exert divergent roles on NF dynamics, including inhibition of proteolysis (MAPk and cdk5; Fig. 5 ), restriction of NF phosphorylation within perikarya and promotion of NF transport into axonal neurites (MAPk and CK1; Fig. 6,7) and promotion of bundling (cdk5, GSK; Fig. 6,7) . Since the collective impact of these diverse functions would foster increased in phospho-NFs within axonal neurites, we considered that increased activity of each of these kinases would contribute either indirectly or directly to the establishment and maintenance of axonal NF bundles. In support of this notion, overexpression of each of these kinases both increased the percentage of neurites displaying NF bundles and cdk5, CK1 and GSK each increased the association of GFP-H with bundles (Fig. 8A,B) . These findings confirm that each of these kinases contributes directly or indirectly to the incorporation of NFs into axonal bundles.
The distal portion of the NF-H C-terminal is essential for bundling
To address further the role of GSK in bundling, we compared incorporation into the bundleenriched fraction of full-length GFP-H with incorporation of GFP-H in which the terminal 187 amino acids (the region of the C-terminal sidearm reported to be essential for bundling (Chen et al., 2000) ) were deleted ("HΔ187"). Cells expressing HΔ187 generated prominent GFP-reactive species migrating at approximately 150kDa on SDS-gels, which corresponds to the anticipated migratory position of 115kDa NF-H (i.e., lacking the terminal 187 amino acids) fused to GFP. Additional slower-migrating GFP-reactive species were observed between 155-175kDa ( Fig. 8C ) that displayed prominent immunoreactivity with antibodies directed against phospho-dependent NF C-terminal epitopes (RT97, SMI34, and SMI31), confirming retention of these epitopes within the proximal portion of the sidearm.
Retardation of migration of phospho-reactive HΔ187 isoforms demonstrates its ability to undergo phospho-mediated conformation alterations that foster retardation of full-length NF-H migration on SDS-gels (Pant and Veeranna, 1995; Shea and Chan, 2008) .
GFP-HΔ187 co-assembled with the endogenous NF network as evidenced by its distribution within the cytoskeleton and co-localization with filamentous profiles (Fig. 8D) . Despite deletion of the portion of the NF-H sidearm purported to mediate NF-NF bundling (i.e., the distal-most 187 amino acid residues of the C-terminal sidearm (Chen et al., 2000) ), GFP-HΔ187 was recovered within bundles both in cellular fractionation and immunofluorescent analyses (Fig. 5B,C) , which was mediated by C-terminal crosslinking among endogenous (full-length) NF-H co-assembled into the same NFs as shown previously (Kushkuley et al., 2009; Lee et al., 2011) .
We next compared the influence of overexpression of GSK and CK1, since the majority of NF-H consensus sites for these kinases exist within the distal-most 187 amino acids (Chen et al., 2000; Hollander and Bennett, 1992; Hollander et al., 1996; Sasaki et al., 2002; Shaw et al., 1997) , on bundling of GFP-H and GFP-HΔ187 (Fig. 8E ). In the absence of kinase overexpression, both GFP-H and GFP-HΔ187 displayed an identical relative distribution within bundles versus the surrounding axoplasm.
However, overexpression of GSK or CK1 each increased the relative amount of GFP-H that was associated with axonal bundles, but did not alter the association of GFP-HΔ187 within bundles.
These findings suggested that GSK-and CK1-mediated phosphorylation of sites within the distal 187 amino acid residues of the NF-H C-terminal tail played a critical role in NF bundling.
DISCUSSION
Key phosphorylation events foster NF-NF associations that generate the stationary phase. Neurons are faced with the task of preventing or eliminating those events within perikarya, which would otherwise result in accumulation of perikaryal spheroids of phospho-NFs characteristic of conditions such as ALS, yet promoting these events within axons, without which the developing axon will not undergo stabilization (Julien and Mushynski, 1998; Pant and Veeranna, 1995; Shea and Lee, 2011; Shea and Lee, 2013) . The findings presented herein elucidate divergent roles for NF kinases and phosphatases that encompass axonal transport and establishment/maintenance of the stationary phase.
These functions were mediated in part by direct phosphorylation of NFs, but also by interactions among kinases and phosphatases.
We demonstrated herein that GSK activity is essential for NF-NF interactions leading to incorporation of NFs into the stationary phase, which is readily viewed in NB2a/d1 cells and cultured neurons as tightly-associated, "bundled" NFs (Kushkuley et al., 2009; Yabe et al., 2001a; Yuan et al., 2009a ). However, GSK-induced bundling was not restricted to axonal neurites but also occurred within perikarya. We demonstrated herein that MAPk, activity of which is essential for transport of NFs into and along axonal neurites of NB2a/d1 cells (Chan et al., 2004) , promotes NF axonal transport by inhibiting GSK activity; increasing MAPk activity increased GSK phosphorylation at ser-9 (which inactivates GSK (Sutherland et al., 1993) ) and prevented GSK-induced NF-NF association, while inhibition of MAPk activity potentiated GSK-induced inhibition of axonal transport and accumulation of NF bundles within perikarya.
CK1 activated PP1, which was essential for translocation of NFs out of perkarya and into axonal neurites; inhibition of CK1 activity or direct inhibition of PP1 fostered accumulation of phospho-NF immunoreactivity and NF bundles within perikarya. This finding suggest that the normal segregation of extensive phosphorylation and resultant NF bundling to axons is achieved by maintaining a relatively higher ratio of phosphatase/kinase activity within perikarya than within axonal neurites. This possibility is consistent with the rapid de novo accumulation of phospho-NF immunoreactivity within retinal ganglion cell perikarya and proximal axons in situ following inhibition of PP2A (Jung and Shea, 1999) .
The above findings demonstrate essential roles for MAPk and CK1 in promotion of NF transport out of perikarya. We did not determine whether or not MAPk and CK1 mediated continued transport of NFs along axonal neurites by their respective inhibition of GSK and activation of PP1. However, transporting NFs enter and leave the stationary cytoskeleton (Kushkuley et al., 2009; Lewis and Nixon, 1988; Nixon and Logvinenko, 1986; Trivedi et al., 2007; Yabe et al., 2001a; Yuan et al., 2009b) ). This finding, coupled with increased phospho-NFs along axons following inhibition of PP1 and PP2A (herein and Shea et al., 1993) suggest the presence of ongoing cycles of NF phosphorylation/dephosphorylation within axons.
In addition to regulation of PP1 activity, CK1 mediated NF-H migratory shift on SDS-gels from 160kDa to 200kDa. Herein, we observed prominent RT97 immunoreactivity with the entire range of NF-H isoforms, including the 160kDa isoform, following CK1 inhibition. This was unexpected, since RT97 immunoreactivity, which is generated by MAPk (Veeranna et al., 2008) , is normally associated with the most highly phosphorylated NF-H isoforms, migrating at while RT97 is normally restricted to the axonal shaft (Jung and Shea, 1999; Sanchez et al., 2000; Yabe et al., 2000) .
The use of SDS-gels containing a relatively low acrylamide content revealed an array of NF-H isoforms similar to those observed in optic pathway (Lewis and Nixon, 1988) . Site-directed mutagenesis of cdk5-specific phosphorylation sites induced minor alterations in migration of NF-H migration on SDS-gels. GSK activity induced RMO-24 reactivity and the appearance of the slowestmigrating NF isoform, corresponding to the 210kDa isoform in optic pathway (Lewis and Nixon, 1988) .
Inhibition of MAPk depleted this slowest-migrating isoform, indicating that a combination of MAPk and
GSK activity generated this isoform.
Phosphorylation inhibits NF proteolysis (Pant and Veeranna, 1995) . Our findings provided further insight into this regulation by demonstrating that phosphorylation by cdk5 and MAPk, and not by CK1
and/or GSK, mediated this protection. We observed increased NF-H proteolysis following simultaneous inhibition of cdk5 and MAPk but not GSK or CK1, and overexpression of GSK and CK1 failed to prevent NF-H proteolysis following inhibition of cdk5 and MAPk. These findings indicate that phosphorylation of the KSP domains provides protection against proteolysis. Since the terminal 187 amino acid residues, which contains the majority of the CK1 and GSK consensus sequences, is essential for bundling (Chen et al., 2000) , one speculation arising from the differential impact of these kinases on proteolysis and bundling is that the terminal 187 amino acid residues, rather than the KSPrich regions, may mediate the cation-dependent crosslinking that incorporates NFs into bundles (Kushkuley et al., 2009) , leaving the more proximal KSP-rich region, or a portion of it, exposed to potential protease activity. If this were indeed the case, dephosphorylation of the KSP-rich region could allow proteolysis of bundled NFs, which may provide a means for localized remodeling of the cytoskeleton, including that required axonal branching (Xie et al., 2006 ).
Comparison of GFP-H within axonal neurites and bundles indicated that CK1, GSK, and cdk5 all
increased bundling of NFs, indicating that once NFs were within axons, all of these kinases contributed to the establishment and maintenance of the stationary phase. However, our systematic overexpression and inhibition highlighted that these kinases regulated an hierarchical series of events encompassing proteases and phosphatases. GSK-mediated NF bundling, required prior phosphorylation of those NFs by cdk5. MAPk-mediated downregulation of GSK activity within perikarya was essential to restrict segregation of bundling within axonal neurites. Like MAPk, CK1 also promoted NF transport into axonal neurites by restricting the accumulation of extensive phosphorylation within perikarya, although CK1 mediated this by activation of PP1 rather than inhibition of GSK. In addition, inhibition of NF proteolysis by cdk5 and MAPk also likely contributed to bundling by maintaining sufficient concentration of axonal NFs. Promotion of NF transport into axons by MAPk and CK1, inhibition of NF proteolysis by MAPk and cdk5, and prior NF phosphorylation at least by cdk5 represent mechanisms by which these kinases could contribute to GSK-induced NF bundling within axons. These findings collectively indicate that the impact on NF dynamics of the non-proline-directed kinases CK1 and GSK are functionally regulated by the proline-directed NF kinases MAPk and cdk5.
A limitation of these analyses is that we did not dephosphorylate NFs prior to examination of the impact of kinase manipulation Accordingly, we cannot completely exclude the possibility that prior phosphorylation events contributed to the changes observed following manipulation of individual kinases. Unfortunately, experimental NF dephosphorylation results in rapid proteolysis within cells (Pant and Veeranna, 1995) and under cell-free conditions due to NF-associated proteases (Kushkuley et al., 2009) . A further limitation is that we were unable to examine the consequences of simultaneous overexpression of multiple kinases. We have routinely manipulated kinases in cells co-tranfected with GFP-H or GFP-M by utilizing 2x of the respective kinase construct versus the GFP-NF construct. To examine the consequence of multiple kinases would require successful triple transfection (i.e., GFP-H plus two or more kinase constructs), which is impractical.
The kinases studied herein have multiple substrates beyond NFs. As such, we cannot exclude the possibility that at least some of the impact of kinase/phosphatase manipulation on NFs as seen hererin was derived by indirect effects on other cellular pathways. For example, while NF phosphorylation clearly provides resistance to proteolysis (Pant and Veeranna, 1995) , we cannot exclude the possibility that manipulation of kinase/phosphatase activities also suppressed activity of proteolytic enzymes themselves, which would further contribute to increased NF levels. Similarly, while phosphorylation promotes NF bundling, and in doing so removes NFs from the transporting pool Kushkuley et al., 2009) , kinases examined herein also directly and indirectly impact kinesin itself (Morfini et al., 2002) . We therefore cannot completely exclude the possibility that at least some of the alterations in NF distribution following kinase/phosphatase manipulations were derived at least in part from disruptions in overall axonal transport. This likelihood is reduced, however, by our prior demonstration that manipulation of MAPk and cdk5 by the same methodologies utilized herein did not alter axonal transport of tau (also dependent upon kinesin) in these cells (Moran et al., 2005; Dubey et al, 2007) . Notably, even if the kinases and phosphatases studied herein mediate some of their impact on NFs by modulation of proteolytic and transport systems, it does not diminish the overall conclusion that the collective impact of these divergent kinase activities increases the amount of phospho-NFs within axonal neurites, which in turn contributes to establishment and maintenance of the stationary phase.
C-terminal NF phosphorylation does not directly interfere with NF axonal transport, but indirectly interferes with transport by allowing some NFs to withdraw from the transporting pool to establish the stationary cytoskeleton, which is essential for axonal maturation. This avoids the need for any alteration in the transport system itself to foster axonal maturation. Notably, this allows continued activity of transport systems within axons. Using the same transport battery throughout neuronal differentiation and maturation simplifies these dynamics, allows stabilization of proximal axonal regions while distal regions are still elongating, and ultimately allows transition into a maintenance system that can repair/replace damaged or worn out NFs at any locus along the axon.
The kinases studied herein share pivotal roles in neuronal homeostasis. Any requirement to modulate their activity to foster NF transport and assembly of the stationary phase would impact multiple essential neuronal pathways. However, since extensively phosphorylated NFs essentially undergo self-assembly to form the stationary phase within axons, there is no apparent requirement for a developing neuron to modulate the activity of these kinases nor their corresponding phosphatases for establishment or repair of the stationary phase. Intermediate filaments (IFs) provide mechanical strength to cells and mediate the formation of tissues (Bertaud et al., 2010; Fuchs, 1994) .. Perhaps nowhere can the need for long-term, stable structural support be more critical than in axons, which, once synaptogenesis has occurred, remain in place for the lifetime of the individual (Shea and Lee, 2013) .
The interplay of kinase and phosphatase activities on NF dynamics as demonstrated herein demonstrate how this class of IFs can establish a long-lasting, supportive macrostructure polarity during development without the need to alter activity of participating kinases or that of the overall transport system.
MATERIALS and METHODS
Differentiation Mouse NB2a/d1 neuroblastoma cells were cultured in DMEM containing 10% fetal bovine serum and differentiated with 1mM dibutyryl cyclic AMP (dbcAMP) (Yabe et al., 1999) . For simplicity and clarity of writing, translocation of NFs into and along axonal neurites of these cells is referred to as "axonal transport."
Expression of NF Constructs Cells were transfected using LipofectAMINE (Invitrogen, Carlsbad, CA) with constructs expressing GFP-tagged full-length NF-H (GFP-H), plasmids expressing GFPtagged isolated NF-H sidearm (i.e., lacking the rod domain; "GFP-Hwt,") GFP-tagged sidearms in which the serines in C-terminal cdk5 consensus sites were mutated to aspartates ("GFP-Hasp") or alanines ("GFP-Hala") to mimic permanently phosphorylated or nonphosphorylated states (Ackerley et al., 2003; Lee et al., 2011) , and GFP-tagged rat NF-H lacking the distal-most C-terminal 187 amino acids (GFP-HΔ187). GFP-HΔ187 was prepared from the above full-length GFP-tagged NF-H construct.
Since there is a unique AccI site in the C-terminal region of rod domain of NF-H (Chen et al., 2000) , the sequence between Acc I and the last KSP motif was amplified by PCR using the following set of primers: 5'-AGAGTCGCCAAAGTGAACACGGATGCT-3' and 5'-CTGAGGATCCTAAGGGGACTTCACTTC-3'. Amplified PCR fragments were digested with AccI and BamHI, for which consensus sites were included in the primers, then cloned into the prepared template plasmid digested with the same enzymes. A ≥ 70% transfection efficiency for GFP-tagged NF constructs is attained under these conditions (Chan et al., 2004) .
Manipulation of kinase activities
Cells were transfected with a plasmid expressing constitutively-active mouse GSK3β ("GSK,"
generous gift from Dr. Chris Miller), mouse CK1-α ("CK1," Origene, Rockville, MD), constititivelyactive MKK1 (upstream activator of MAPk) (Li et al., 1999) , MAPk, and p25 (the truncated and constitutively-active form of the cdkd5 activator p35 (Patrick et al., 1999) . Additional cultures were treated with the pharmacological inhibitors roscovitine (20µM), PD98059 (10µM), lithium (10mM), D4476 (100µM), and tetraBromoBenzoleTriazole (tBBT; 60µM), which are active against cdk5, MKK1, GSK, CK1 and CK2 respectively (Cheng et al., 1983; Dudley et al., 1995; Meijer et al., 1997; Rena et al., 2004; Sarno et al., 2001) . Since the downstream impact of manipulation of MKK1 on NFs is alteration of p42/44 MAP kinase, we refer to MAPk manipulation at points for simplicity of writing.
For co-transfection with kinases and GFP-H, ≥ 2x of kinase constructs versus GFP-H were utilized (1μg and 0.5μg respectively); insuring that cells displaying GFP were cotransfected with the kinase construct (Chan et al., 2004; Shea et al., 2004) .
Fractionation
Cells were homogenized in 50mM Tris-HCl (pH 6.8) containing 1% Triton X-100, 5mM EDTA, 1mM PMSF and 50µg/ml leupeptin and centrifuged (15,000 x g; 15min). The resulting pellet was defined as the Triton-insoluble cytoskeleton, and the resulting supernatant was defined as the Tritonsoluble fraction. Spinal cord NFs from adult C57BL6 mice of both genders (sacrificed in accordance with the approval of our Institutional Animal Care and Use Committee) were resuspended in 0.1M MES (pH6.8) containing 1mM MgCL2, 1mM EGTA, 1mM PMSF and 50 μ g/ml leupeptin and labeled with rhodamine as described (Kushkuley et al., 2009; Wagner et al., 2003) .
To obtain fractions enriched in bundled NFs, additional homogenates were layered over the same buffer containing 1M sucrose, and centrifuged 15,000 x g; 15min). Bundled NFs sedimented through the sucrose cushion; "individual" NFs (not contained within bundles) were recovered at the sucrose interface (Kushkuley et al., 2009; Yabe et al., 2001a) . Protein concentration was determined by BCA assay (Thermo scientific).
Cell-free NF manipulations
Individual NFs obtained as described above were incubated ± purified kinases (Kushkuhley et al., 2009 ) for 2hr at 37 o C with 0.1μg/μl cdk5 and its activator p35, MAPk, and/or GSK (Upstate Biochemicals, Lake Placid, NY). The % of NFs aligned with ≥ 3 other NFs were quantified via fluorescence microscopy (Kushkuley et al., 2009 ). Closely-aligned NFs typically splay apart at their ends, facilitating detection of multiple NFs (Kushkuley et al., 2009) .
Electrophoresis and Immunoblot analysis
Samples were normalized according to total protein, subjected to SDS-gel electrophoresis and transferred to nitrocellulose. The bundled fraction was solubilized with 8M urea for electrophoresis.
Membranes were blocked with 5% BSA and 5mM sodium fluoride in Tris-buffered saline containing Journal of Cell Science Accepted manuscript (R39) (Jung and Shea, 1999) . Membranes were washed with the same buffer then incubated with alkaline phosphatase-conjugated secondary antibodies for 1hr at room temperature and developed using a NBT/BCIP substrate kit (Promega, Madison, WI).
Immunoreactive species were quantified in digitized images of replicas using Image J; the background signal from an adjacent, identically-sized area in the identical lane was subtracted from each reactive species (Yabe et al., 2001a; Yabe et al., 1999) . All samples to be compared were electrophoresed on the same gel, transferred to nitrocellulose and visualized simultaneously.
Immunofluorescence
Cells grown on poly-L-Lysine-treated coverslips were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS; pH 7.4) for 10 minutes at room temperature, rinsed 2x in PBS (5min/rinse), and blocked for 30min in PBS containing 1% bovine serum albumin (BSA) and 2% normal goat serum. Cultures were then incubated overnight at 4 o C in PBS containing 1% BSA and a 1:500 dilution anti-GFP or R39, or 1:100 dilutions of RT97, SMI34, SMI-31, SMI-32, and RMO-24.
Cultures were rinsed 3x with PBS, incubated for 30min at 37 o C in PBS containing 1% BSA and a 1:300 dilutions of appropriate secondary antibodies.
Monitoring of intracellular NF distribution
NF distribution was quantified using Image J (http://rsb.infor.nih.gov/ij). Translocation of NF constructs into and along axonal neurites was quantified as an index of axonal transport. The shaft of axonal neurites was divided into 10 equivalent segments excluding the hillock and the growth cone, and the % GFP within each segment was calculated relative to the total GFP within the axonal shaft (Yabe et al., 2001b) . In additional studies, axonal neurites (>25 for each condition) were divided into 3 equivalent segments (defined as proximal, central and distal) excluding the hillock and growth cone. The translocation rate was determined by dividing the GFP intensity in the distal fragment by that of central fragment within each neurite (Chan et al., 2004) . To monitor the extent of incorporation of GFP-tagged NFs into axonal NF bundles, GFP intensity of the bundle and that of the area adjacent to the bundle were quantified within the central neurite segment for >20 cells for each condition (Chan et al., 2004; Chan et al., 2005) .
Kinase and Phosphatase Assays
GSK activity was assayed by monitoring phosphorylation of GSK at ser9 (which inactivates GSK) and phosphorylation of the GSK substrate beta-catenin at Ser33/37/Thr41. Homogenates of cells ± GSK overexpression or lithium treatment treated with 10mM lithium were subjected to electrophoresis, transferred to nitrocellulose and probed with antibodies directed against total GSK, GSK that had been phosphorylated at ser9, total beta-catenin, and beta-catenin phosphorylated at Ser33/37/Thr41 (Cell Signaling), and anti-tubulin antibody DM1A as a loading control. Since beta-catenin is degraded once phosphorylated by GSK (Ding et al., 2005) , a decrease in phospho-beta catenin (also be reflected in total beta-catenin levels) provides an index of GSK activity.
CK1 activity was monitored by casein gel zymology (Cheng and Louis, 1999) . Lysates from cells incubated for 4 hours ± 100µM D4476 were separated on a 12% polyacrylamide gel polymerized in the presence of 1mg/ml dephosphorylated casein. After electrophoresis, SDS was removed from the gel by The gel was equilibrated in 10mM Tris-HCl (pH 7.5) containing 10mM MgCl 2 for 30min at room temperature. Casein phosphorylation was carried out by incubation of the gel in 10mM Tris-HCl (pH 7.5) containing 10mM MgCl 2 , 25μM ATP and 2.5 μ Ci /ml, [γ-32 P] ATP for 2h at room temperature followed by washing with 5% trichloroacetic acid/1% sodium pyrophosphate until no radioactivity was detected in the wash. The gel was dried and exposed to X-ray film.
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Supported by the National Science Federation. Transfection with a construct expressing GSK significantly (p<0.05) increased overall GSK levels (which increases net GSK activity (Wagner et al., 1996) ), and decreased levels of the GSK substrate beta catentin (proteolyzed following GSK-mediated phosphorylation). Lithium significantly increased levels of GSK phosphorylated at ser9 (which inactivates GSK (Lamarre and Desrosiers, 2008) and prevented degradation of phospho-and total beta-catentin. Beta-tubulin (probed with antibody DM1A) was included as a loading control. The accompanying graphs present the mean ± standard error for 3 immunoblots for total and phospho GSK (pser9-GSK) and 2 for phospho-(p-) and total beta-catentin. 
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